Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Leonor M Almeida"'
Autor:
Sónia R Pereira, Rita Pereira, Isabel Figueiredo, Victor Freitas, Teresa C P Dinis, Leonor M Almeida
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174116 (2017)
Despite the actual therapeutic approaches for inflammatory bowel disease (IBD), efficient and secure alternative options remain a research focus. In this context, anthocyanins seem promising natural anti-inflammatory agents, but their action mechanis
Externí odkaz:
https://doaj.org/article/a3d27ce5ca44444ca2254dcd4ee17d17
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109048 (2014)
Many advances have been recently made focused on the valuable help of dietary polyphenols in chronic inflammatory diseases. On the other hand, current treatment options for intestinal bowel disease patients are unsatisfying and, for this reason, it i
Externí odkaz:
https://doaj.org/article/325ac200c35647b98e88b6b07a9f349e
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73001 (2013)
The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated. Cyanidin-3-glucoside is a typica
Externí odkaz:
https://doaj.org/article/e1a0d8acfa434b0987461d6f2f86e906
Publikováno v:
Journal of Functional Foods, Vol 63, Iss , Pp - (2019)
This study investigated the anti-inflammatory action of cyanidin-3-glucoside (Cy3glc), an anthocyanin widely spread in diet, in comparison and in association with 5-aminosalicylic acid (5-ASA), an anti-inflammatory reference drug for ulcerative colit
Externí odkaz:
https://doaj.org/article/68f7bbd78710433e8e6a68bf66e7c640
Autor:
Diana Serra, Joana F. Henriques, Teresa Serra, Andreia Bento Silva, Maria Rosário Bronze, Teresa C. P. Dinis, Leonor M. Almeida
Publikováno v:
Nutrients, Vol 12, Iss 12, p 3670 (2020)
Dietary polyphenols are multi-target compounds that have been considered promising candidates in strategies for the mitigation of neurological diseases, acting particularly through reduction of microglia-driven neuroinflammation. In this study, an an
Externí odkaz:
https://doaj.org/article/6887c3b7d5904a92881fc1acf3b9d602
Publikováno v:
Molecular Neurobiology. 56:6941-6951
It has been shown that the gut microbiota plays a crucial role in the maintenance of intestinal homeostasis. Additionally, it has been demonstrated that dysbiosis is closely correlated with chronic intestinal inflammation, contributing to the develop
Publikováno v:
Food & Function. 10:1364-1374
The altered expression and subcellular distribution of tight junction (TJ) proteins, leading to a dysfunctional intestinal barrier, is a key mechanistic feature of inflammatory bowel disease (IBD). Therefore, increasing the integrity of the intestina
Autor:
Leonor M. Almeida, Maria Rosário Bronze, Teresa C.P. Dinis, Andreia Silva, Teresa Serra, Diana Serra, Joana Henriques
Publikováno v:
Nutrients, Vol 12, Iss 3670, p 3670 (2020)
Nutrients
Volume 12
Issue 12
Nutrients
Volume 12
Issue 12
Dietary polyphenols are multi-target compounds that have been considered promising candidates in strategies for the mitigation of neurological diseases, acting particularly through reduction of microglia-driven neuroinflammation. In this study, an an
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8653, p 8653 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Anthocyanins are naturally occurring polyphenols commonly found in fruits and vegetables. Numerous studies have described that anthocyanin-rich foods may play a crucial role in the prevention and treatment of different pathological conditions, which
Autor:
David Jorge Araújo Barros Coelho, Gabriela Fernandes, Adriana Magalhães, Leonor M. Almeida, Henrique Queiroga, Hélder Novais-Bastos, Maria Jacob, Conceição Souto Moura, Luis Cirnes, Venceslau Hespanhol, Catarina Sousa, David Araújo
Publikováno v:
Lung cancer.
Introduction: For non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations, tyrosine kinase inhibitors (TKIs) are the therapy of choice, with proved efficacy of osimertinib in case of progression with T790M e